Melperone HCl
13104A
Phase 2 small_molecule completed
Quick answer
Melperone HCl for Parkinson's Disease is a Phase 2 program (small_molecule) at Lundbeck Australia Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lundbeck Australia Pty Ltd
- Indication
- Parkinson's Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed